Entrada Therapeutics TRDA
NASDAQ TRDA
$5.21 -0.47 (-8.27%)
As of: Oct 2, 2026 · 1:04 PM EDT

Entrada Therapeutics (TRDA) Depreciation and Depletion (2020 - 2026)

Updated

Entrada Therapeutics (TRDA) recorded Depreciation and Depletion of $800,000 in Q2 2026, down 27.3% from $1.1 million a year earlier and down 0.6% from the prior quarter.

Analysis

Entrada Therapeutics (TRDA) Depreciation and Depletion (2020 - 2026) Analysis & Trends

On a TTM basis, Entrada Therapeutics' Depreciation and Depletion came in at $3.7 million as of Jun 30, 2026, down 6.4% year-over-year; for FY2025, it was $4.1 million, up 7.9% from FY2024.

  • Annual Depreciation and Depletion has increased for five straight years, with a five-year compound annual growth rate of 65.9% (FY2020 to FY2025).
  • Across earlier years, Depreciation and Depletion came in at $3.8 million in FY2024 (+33.8%), $2.84 million in FY2023 (+49.5%), $1.9 million in FY2022 (+70.1%) and $1.12 million in FY2021 (+242.6%).
  • The Q2 2026 figure is the lowest quarterly Depreciation and Depletion since Q4 2023.
  • On a year-over-year basis, Depreciation and Depletion has declined for three consecutive quarters, with growth averaging 6.5% over the last eight quarters.
  • Peak year-over-year performance for Depreciation and Depletion in the last five years was growth of 223.5% in Q4 2021, against a decline of 27.3% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $805,000 (Q1 2026), $890,000 (Q4 2025) and $1.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Entrada Therapeutics 247.25 Mn 247.25 Mn - 800,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 800,000.00
Mar 31, 2026 805,000.00
Dec 31, 2025 890,000.00
Sep 30, 2025 1.20 Mn
Jun 30, 2025 1.10 Mn
Mar 31, 2025 946,000.00
Dec 31, 2024 1.00 Mn
Sep 30, 2024 900,000.00
Jun 30, 2024 900,000.00
Mar 31, 2024 934,000.00
Dec 31, 2023 736,000.00
Sep 30, 2023 800,000.00
Jun 30, 2023 700,000.00
Mar 31, 2023 541,000.00
Dec 31, 2022 500,000.00
Sep 30, 2022 500,000.00
Jun 30, 2022 500,000.00
Mar 31, 2022 400,000.00
Dec 31, 2021 317,000.00
Sep 30, 2021 300,000.00
API Access

Entrada Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=TRDA&period=max&api_key=YOUR_API_KEY